These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21781490)

  • 21. [Primary study of arsenic trioxide inhibits abdomino-metastatic tumor formation of human ovarian carcinoma in nude mice and its mechanisms].
    Huang SG; Kong BH; Yang RF; Jiang S
    Ai Zheng; 2002 Apr; 21(4):401-4. PubMed ID: 12452020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
    Chien CW; Yao JH; Chang SY; Lee PC; Lee TC
    Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells.
    Kim SH; Yoo HS; Joo MK; Kim T; Park JJ; Lee BJ; Chun HJ; Lee SW; Bak YT
    BMC Cancer; 2018 Feb; 18(1):150. PubMed ID: 29409467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of baicalin on HL-60 cell xenografts in nude mice and its mechanism].
    Zheng J; Hu JD; Huang Y; Chen YY; Li J; Chen BY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1066-71. PubMed ID: 23114120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of arsenic trioxide combined with aspirin on the growth of human gastric adenocarcinoma graft in nude mice].
    Qiu J; Wu YP; Liu H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 May; 29(5):418-21. PubMed ID: 19673332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor.
    Monzen H; Griffin RJ; Williams BW; Amano M; Ando S; Hasegawa T
    Radiat Med; 2004; 22(4):205-11. PubMed ID: 15468939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice.
    Hann HW; Stahlhut MW; Rubin R; Maddrey WC
    Cancer; 1992 Oct; 70(8):2051-6. PubMed ID: 1327484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid.
    Campbell RA; Sanchez E; Steinberg JA; Baritaki S; Gordon M; Wang C; Shalitin D; Chen H; Pang S; Bonavida B; Said J; Berenson JR
    Br J Haematol; 2007 Aug; 138(4):467-78. PubMed ID: 17587338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma.
    Chen G; Wang Y; Huang H; Lin F; Wu D; Sun A; Chang H; Feng Y
    Eur J Haematol; 2009 Mar; 82(3):176-83. PubMed ID: 19077051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
    Song J; Zhao Z; Fan X; Chen M; Cheng X; Zhang D; Wu F; Ying X; Ji J
    Oncotarget; 2016 Oct; 7(43):70504-70515. PubMed ID: 27655700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Apoptosis of NB4 cells induced by Tanshinone II A combined with arsenic trioxide].
    Zhang G; Yang YM; Meng WT; Zhou J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):57-61. PubMed ID: 20369471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy with 5-amino-4-imidazolecarboxamide riboside and arsenic trioxide in acute myeloid leukemia cells involving AMPK/TSC2/mTOR pathway.
    Chen L; Han F; Qu H; Yan H; Ren L; Yang S
    Pharmazie; 2013 Feb; 68(2):117-23. PubMed ID: 23469683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor effect of arsenic trioxide in murine xenograft model.
    Kito M; Matsumoto K; Wada N; Sera K; Futatsugawa S; Naoe T; Nozawa Y; Akao Y
    Cancer Sci; 2003 Nov; 94(11):1010-4. PubMed ID: 14611680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice.
    Rousselot P; Larghero J; Labaume S; Poupon J; Chopin M; Dosquet C; Marolleau JP; Janin A; Brouet JC; Fermand JP
    Eur J Haematol; 2004 Mar; 72(3):166-71. PubMed ID: 14962234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bcl-2 hijacks the arsenic trioxide resistance in SH-SY5Y cells.
    Wang J; Peng X; Yang D; Guo M; Xu X; Yin F; Wang Y; Huang J; Zhan L; Qi Z
    J Cell Mol Med; 2022 Jan; 26(2):563-569. PubMed ID: 34910369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitory effect of arsenic trioxide combined with cisplatin on human nasopharyngeal carcinoma xenograft and DAPK in nude mice].
    Huang X; Wang X; Hu J; Zhou H; Zhou K; Zhang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):479-83. PubMed ID: 23898615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway.
    Qu H; Tong D; Zhang Y; Kang K; Zhang Y; Chen L; Ren L
    Pharmazie; 2013 Oct; 68(10):839-45. PubMed ID: 24273890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
    Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carnosic Acid-combined Arsenic Trioxide Antileukaemia Cells in the Establishment of NB4/SCID Mouse Model.
    Hao L; Ran W; Xiang-Xin L; Lu-Qun W; Xiao-Ning Y
    Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):259-66. PubMed ID: 26998898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.